Live Breaking News & Updates on Johnson Johnsonjnjannounced

Stay updated with breaking news from Johnson johnsonjnjannounced. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial - Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson reported successful Phase 3 trial results for seltorexant, an investigational treatment for major depressive disorder with insomnia. ....

United-states , American , Johnson-johnsonjnjannounced , American-society-of-clinical-psychopharmacology , Johnson , American-society , Clinical-psychopharmacology , Numab-therapeutics ,